ZIMMER BIOMET HOLDINGS, INC. Proceeds from Issuance of Senior Long-term Debt
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Proceeds from Issuance of Senior Long-term Debt of $2.49 billion for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt · last filed 2026-08-05
- ZIMMER BIOMET HOLDINGS, INC. proceeds from issuance of senior long-term debt for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. proceeds from issuance of senior long-term debt for the quarter ending 2025-09-30 was $744.00M.
- ZIMMER BIOMET HOLDINGS, INC. proceeds from issuance of senior long-term debt for the quarter ending 2025-06-30 was $0.00.
- ZIMMER BIOMET HOLDINGS, INC. proceeds from issuance of senior long-term debt for the quarter ending 2025-03-31 was $1.75B.
- ZIMMER BIOMET HOLDINGS, INC. proceeds from issuance of senior long-term debt for fiscal 2025 was $2.49B, a 73.51% increase from fiscal 2024.
- ZIMMER BIOMET HOLDINGS, INC. proceeds from issuance of senior long-term debt for fiscal 2024 was $1.44B, a 187.37% increase from fiscal 2023.
- ZIMMER BIOMET HOLDINGS, INC. proceeds from issuance of senior long-term debt for fiscal 2023 was $499.80M.
- ZIMMER BIOMET HOLDINGS, INC. proceeds from issuance of senior long-term debt for fiscal 2020 was $1.50B.
| Period end | Proceeds from Issuance of Senior Long-term Debt | Proceeds from Issuance of Senior Long-term Debt 0 month | Proceeds from Issuance of Senior Long-term Debt 1 month | Proceeds from Issuance of Senior Long-term Debt 1 month as first filed | Proceeds from Issuance of Senior Long-term Debt 3 month | Proceeds from Issuance of Senior Long-term Debt 6 month | Proceeds from Issuance of Senior Long-term Debt 9 month | Proceeds from Issuance of Senior Long-term Debt 12 month |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $744.00M derived: sum of 2 quarters · filed 2026-02-20 | $744.00M derived: sum of 3 quarters · filed 2026-08-05 | $2.49B 10-K · filed 2026-02-20 | ||||
| 2025-09-30 | $744.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $744.00M derived: sum of 2 quarters · filed 2026-08-05 | $2.49B 10-Q · filed 2025-11-05 | $3.23B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.75B 10-Q · filed 2026-08-05 | $2.48B derived: sum of 3 quarters · filed 2026-08-05 | |||||
| 2025-03-31 | $1.75B 10-Q · filed 2026-05-01 | $2.48B derived: sum of 2 quarters · filed 2026-05-01 | ||||||
| 2024-12-31 | $736.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $1.44B 10-K · filed 2026-02-20 | ||||||
| 2024-11-20 | $736.30M 10-K · filed 2025-02-25 | |||||||
| 2024-09-30 | $700.00M 10-Q · filed 2025-11-05 | |||||||
| 2024-08-15 | $700.00M 10-K · filed 2025-02-25 | |||||||
| 2023-12-31 | $499.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $499.80M 10-K · filed 2026-02-20 | ||||||
| 2023-11-28 | $499.80M 8-K · filed 2024-08-07 | |||||||
| 2023-09-30 | $0.00 10-Q · filed 2024-10-30 | |||||||
| 2021-12-31 | $1.60B 8-K · filed 2024-08-07 | |||||||
| 2021-11-24 | $1.60B 10-K · filed 2023-02-24 | |||||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $0.00 derived: sum of 2 quarters · filed 2023-02-24 | $0.00 derived: sum of 3 quarters · filed 2023-02-24 | $1.50B 10-K · filed 2023-02-24 | ||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | $1.50B 10-Q · filed 2021-11-04 | |||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $1.50B 10-Q · filed 2021-08-03 | ||||||
| 2020-03-31 | $1.50B 10-Q · filed 2021-05-04 | |||||||
| 2019-12-31 | $549.20M 8-K · filed 2022-06-22 | |||||||
| 2019-11-15 | $549.20M 10-K · filed 2021-02-22 | |||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $0.00 derived: sum of 2 quarters · filed 2021-02-22 | $0.00 derived: sum of 3 quarters · filed 2021-02-22 | $749.50M 10-K · filed 2021-02-22 | ||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $0.00 derived: sum of 2 quarters · filed 2019-11-05 | $749.50M 10-Q · filed 2019-11-05 | |||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $749.50M 10-Q · filed 2019-08-05 | ||||||
| 2018-03-31 | $749.50M 10-Q · filed 2019-05-06 | |||||||
| 2018-03-19 | $749.50M 10-K · filed 2021-02-22 | |||||||
| 2016-12-31 | $1.07B 10-K · filed 2019-02-26 | |||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | $0.00 derived: sum of 3 quarters · filed 2018-02-27 | $7.63B 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $0.00 derived: sum of 2 quarters · filed 2015-11-09 | $7.63B 10-Q · filed 2015-11-09 | |||||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $7.63B 10-Q · filed 2015-08-10 | ||||||
| 2015-03-31 | $6.55B 10-K · filed 2017-03-01 | $7.65B 10-Q · filed 2015-08-10 | $7.63B 10-Q · filed 2015-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |